Acorah Software Products - Accounts Production16.5.460falsetruefalsetrueNo description of principal activity1 March 202428 February 202528 February 202515474079Mrs Thunicia Moodleyiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure154740792024-02-29154740792025-02-28154740792024-03-012025-02-2815474079frs-core:CurrentFinancialInstruments2025-02-2815474079frs-bus:PrivateLimitedCompanyLtd2024-03-012025-02-2815474079frs-bus:FilletedAccounts2024-03-012025-02-2815474079frs-bus:Micro-entities2024-03-012025-02-2815474079frs-bus:AuditExempt-NoAccountantsReport2024-03-012025-02-2815474079frs-bus:Director12024-03-012025-02-28
Registered number: 15474079
Biometis Consultancy Ltd
Unaudited Financial Statements
For The Year Ended 28 February 2025
Biometis Consultancy Ltd
Balance Sheet
As At 28 February 2025
Balance Sheet
Registered number: 15474079
2025
£
Current assets
13,203
Creditors: Amounts Falling Due Within One Year
(5,082)
NET CURRENT ASSETS
8,121
TOTAL ASSETS LESS CURRENT LIABILITIES
8,121
Accruals and deferred income
(580)
NET ASSETS
7,541
CAPITAL AND RESERVES
7,541
Notes
1.General Information
Biometis Consultancy Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15474079. The registered office is 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ.
2.Average Number of Employees
Average number of employees, including directors, during the year was: NIL
-
For the year ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.